• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Stem cells and development

    Stem cells and development

    JournalISSN 1547-3287eISSN 1557-8534中科院 医学 4区

    年发文量

    研究主题

    论文(3349)

    排序
    1Serial Passaging Drives Inflammatory–Metabolic Reprogramming and Replicative Senescence in Human Umbilical Cord Mesenchymal Stem Cells
    XiaoXin Wang,BenJiao Gong, YuXiao Zhang, JiaLu Wei, JiaLe Dong,XueXia Liu,FuJun Liu

    Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) are widely used in regenerative medicine, but in vitro expansion alters their molecular and functional properties. Understanding replicative senescence trajectories is critical for optimizing cell manufacturing. We performed longitudinal RNA sequencing across passages P3, P6, P9, P12, and P15, using P6 as a clinical reference. Transcriptomic dynamics were bioinformatically analyzed and validated by targeted quantitative real-time PCR. Functional assays assessed senescence-associated β-galactosidase (SA-β-gal) activity, mitochondrial membrane potential, iron accumulation, and glucose uptake. Transcriptomic profiling revealed progressive, passage-dependent divergence with an inflection point after P9. Late-passage cells (P12, P15) exhibited coordinated upregulation of proinflammatory pathways (TNFα, IL-17, and MAPK) and senescence programs, alongside downregulation of oxidative phosphorylation and autophagy. Functional validations confirmed that P12 cells acquired a senescent phenotype: enhanced SA-β-gal, mitochondrial depolarization, iron overload, and a glycolytic shift. Molecular analyses corroborated increased expression of senescence-associated secretory phenotype factors (IL6, CCL2) and glucose transporters (SLC2A1), with suppression of mitochondrial genes (MT-CO2, MT-ND4). P6 cells maintained stable profiles and robust integrity. Serial passaging drives hUC-MSCs toward senescence through bidirectional reprogramming of inflammation and metabolism. Our findings identify P6–P9 as a safe manufacturing window and propose metabolic and iron-related markers for quality control of clinical-grade MSCs, ensuring therapeutic potency.

    2026
    引用
    AI阅读
    加入学术空间
    2Stem Cell-Based Regenerative Strategies for Bone Aging: Current Advances and Future Perspectives.
    Seyyed Hossein Khatami,Faezeh Gouhari,Meisam Jafari Kafiabadi,Sajad Ehtiati, Ahmad Reza Ahmadi Abdashti, Mohsen Ariannik, Diba Rafienejad,Shahin Talebi, Parasta Heidari,Mina Fakhrzadegan,Reza Zandi

    Bone aging is characterized by a progressive decline in skeletal regenerative capacity, driven by stem-cell senescence, chronic inflammation, impaired vascularization, metabolic dysfunction, and alterations in the bone marrow niche. These changes contribute to osteoporosis, delayed fracture healing, and reduced bone quality in older individuals. Stem cell-based therapies have emerged as promising strategies to restore bone regeneration, with investigations focusing on mesenchymal stromal cells, skeletal stem cells, adipose-derived stromal cells, induced pluripotent stem cell-derived osteogenic progenitors, and cell-free approaches such as extracellular vesicles and secretomes. This narrative review examines the biological mechanisms underlying bone aging, the impact of the aged microenvironment on stem-cell function, and current approaches to rejuvenate skeletal regeneration. We discuss advances in tissue engineering, including biomaterials, 3D-printed scaffolds, controlled-release systems, and multifunctional constructs designed to modulate inflammation, enhance angiogenesis, and improve osteogenesis. Preclinical studies consistently demonstrate beneficial effects on bone formation, microarchitecture, and repair; however, translation to clinical practice remains limited. Human studies have primarily focused on fracture nonunion and focal bone defects, showing encouraging safety and feasibility but insufficient evidence for systemic treatment of age-related skeletal fragility. Major barriers include cellular heterogeneity, manufacturing and regulatory challenges, inadequate potency assays, and the complexity of the aged bone niche. Future success will likely depend on integrated therapeutic strategies that simultaneously target progenitor-cell dysfunction and the local microenvironment while ensuring reproducible, scalable, and clinically meaningful outcomes. These advances may pave the way toward effective regenerative therapies for osteoporosis and age-related bone loss.

    2026
    引用
    AI阅读
    加入学术空间
    3Genetically Defined Acute Myeloid Leukemia Induced Pluripotent Stem Cell Clones Reveal Selective Impairment of Hematopoietic Development
    Deanna P. Porras,Amy Qiao,Meaghan Doyle, Hailey Kadonoff,Kinga Vojnits,Diana Golubeva,Cameron G. Hollands,Allison Boyd, Mickie Bhatia

    Patient-derived induced pluripotent stem cells (iPSCs) provide a renewable model for studying acute myeloid leukemia (AML), but whether AML-iPSCs faithfully preserve the functional heterogeneity of genetically distinct AML clones remains unclear. Here, we functionally characterized a genetically defined AML-iPSC resource comprising 34 AML-iPSC lines from 11 AML patients, with complementary assays performed across partially overlapping subsets of lines. AML-iPSC lines were classified as aberration-positive (Ab+) or aberration-negative (Ab-) based on retention of the clinically defining patient-specific leukemia-associated genetic abnormalities. Representative Ab+ and Ab- AML-iPSC lines derived from donor hematopoietic cells exhibited comparable differentiation capacity across nonhematopoietic lineages, whereas Ab+ AML-iPSC lines demonstrated reduced hematopoietic differentiation, as determined by phenotypic analysis and functional colony-forming assays. Across overlapping subsets of AML-iPSC lines, these clone-specific hematopoietic phenotypes were conserved across four independent differentiation platforms, supporting that they reflect stable clone-specific properties rather than methodological artifacts. Residual hematopoietic progenitors derived from Ab+ AML-iPSC lines retained leukemic features, including persistence of leukemia-associated genetic abnormalities, immature blast-like morphology, and enhanced serial replating capacity indicative of self-renewal-associated properties. In a representative paired patient model, these progenitors also demonstrated persistent myeloid-skewed hematopoietic output following xenotransplantation. Together, these findings establish a renewable platform for mechanistic studies investigating how clonal heterogeneity contributes to disease evolution and therapeutic resistance in AML following pluripotent reprogramming.

    2026
    引用
    AI阅读
    加入学术空间
    4CXM102 Regulates the Multiple Differentiation and Anti-Inflammation of Human Bone Marrow-Derived Leptin Receptor-Positive Stromal Cells in Vitro
    Dawei Qiu, Junmo Chen, Xiaoyan Liu, Yiran Dai, Yongliang Huang, Tanghua Wang, Ying Zhang,Ziwei Luo

    Bone marrow-derived leptin receptor-expressing (LepR+) stromal cells (LepR+ BMSCs) have been identified as the primary source of osteoblasts, adipocytes, and fibroblasts in the bone marrow, and they play key roles in the maintenance of the bone marrow microenvironment; however, research on the fate and immunomodulatory changes of human LepR+ BMSCs is limited. Here, we isolated LepR+ BMSCs from a young donor and studied their fate changes of osteogenic, adipogenic, myogenic differentiation, and immunomodulation with or without CXM102, a novel compound that we have previously demonstrated its anti-osteoporotic effects in mice. Our results showed that CXM102 facilitated a preferential lineage shift toward osteogenesis from adipogenesis of LepR+ BMSCs in vitro, as evidenced by increased RUNX 2 expression and decreased PPAR gamma in a bivalent differentiation system. Moreover, interleukin-6 (IL-6), interleukin-1 beta (IL-1 beta), and tumor necrosis factor-alpha (TNF-alpha) were markedly downregulated in HS-5 stromal cells cocultured with conditioned medium from CXM102-treated LepR+ BMSCs. Furthermore, CXM102 also inhibited collagen I deposition in LepR+ BMSCs when induced into myogenesis. These results demonstrated that CXM102 could promote osteogenesis, but inhibit adipogenesis and myogenesis of LepR+ BMSCs, while also showing benign immunomodulation in vitro.

    2026
    引用
    AI阅读
    加入学术空间
    5Precision Diagnostics in Bone Disease: the Potential of Circulating and Stem Cell-Associated Mirnas As Minimally Invasive Biomarkers
    Seyyed Hossein Khatami, Faezeh Gouhari,Adel Ebrahimpour, Sajad Ehtiati, Ahmad Reza Ahmadi Abdashti, Mohsen Ariannik, Diba Rafienejad,Shahin Talebi, Parasta Heidari,Reza Zandi

    Stem cell-associated microRNAs (miRNAs) have emerged as pivotal regulators of osteogenesis, influencing lineage commitment, differentiation, and skeletal tissue homeostasis. Their dysregulation has been increasingly linked to a spectrum of osteogenic disorders, including osteoporosis, osteoarthritis, and impaired fracture healing. This narrative review synthesizes current evidence on the diagnostic potential of stem cell-associated miRNAs in bone-related pathologies. We highlight their roles in modulating osteoblast and osteoclast activity, maintaining mesenchymal stem cell fate, and orchestrating signaling pathways such as Wnt/β-catenin, bone morphogenetic protein, and Notch. Particular emphasis is placed on circulating miRNAs as minimally invasive biomarkers, offering prospects for early detection, disease stratification, and monitoring therapeutic response. Furthermore, we discuss methodological advances in miRNA profiling, challenges in clinical translation, and the need for standardized validation frameworks. By integrating molecular insights with translational perspectives, this review underscores the promise of stem cell-associated miRNAs as diagnostic tools in osteogenic disorders, while identifying critical gaps that must be addressed to enable their incorporation into precision medicine strategies.

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 3349 篇论文

    高被引作者

    作者引用发文
    Qin Han219420
    Charles S Cox19866
    Matthew Harting19055
    Fernando Jimenez18894
    Robert Chunhua Zhao187735
    Sean I. Savitz18326
    Glen A. Laine16391
    Monzon-Posadas Werner O16391
    Uwe Fischer16391
    Hasen Xue16391

    高产作者

    作者引用发文
    Robert Chunhua Zhao187735
    Hal E. Broxmeyer82825
    Hossein Baharvand100723
    Mahendra S. Rao105921
    Qin Han219420
    Graham C. Parker32920
    Paul R. Sanberg152619
    Stan Gronthos105616
    Martin J. Hoogduijn112115
    Ernst Wolvetang45114

    相关期刊

    Stem Cells
    Cell transplantation
    Cells, tissues, organs
    Current stem cell research & therapy
    Stem cells translational medicine
    International journal of stem cells
    NPJ Regenerative medicine
    Stem Cell Reviews and Reports
    Stem Cells International
    World Journal of Stem Cells